About Ori Biotech
Ori Biotech is a company based in London (United Kingdom) founded in 2015 by Chris Mason and Farlan Veraitch.. Ori Biotech has raised $281.12 million across 6 funding rounds from investors including Novalis LifeSciences, Puhua Capital and Chimera Investment. Ori Biotech operates in a competitive market with competitors including Orgenesis, MaSTherCell, Cognate Bioservices, SpliSense and eXmoor, among others.
- Headquarter London, United Kingdom
- Founders Chris Mason, Farlan Veraitch
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oribiotech Ltd
- Date of Incorporation 02 Sep, 2015
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$281.12 M (USD)
in 6 rounds
-
Latest Funding Round
$138.7 M (USD), Series B
Jun 22, 2022
-
Investors
Novalis LifeSciences
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Ori Biotech
Ori Biotech has successfully raised a total of $281.12M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $138.7 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $138.7M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - Ori Biotech | Valuation |
investors |
|
| Jan, 2022 | Amount | Series B - Ori Biotech | Valuation | Novalis LifeSciences | |
| Sep, 2020 | Amount | Series A - Ori Biotech | Valuation | Northpond Ventures , Octopus Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ori Biotech
Ori Biotech has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Novalis LifeSciences, Puhua Capital and Chimera Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and advisory services are provided for life sciences.
|
Founded Year | Domain | Location | |
|
Health and technology startups are invested in by Puhua Capital.
|
Founded Year | Domain | Location | |
|
A private investment firm focused on regional opportunities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ori Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ori Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ori Biotech Comparisons
Competitors of Ori Biotech
Ori Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, MaSTherCell, Cognate Bioservices, SpliSense and eXmoor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
Limited information available
|
|
| domain | founded_year | HQ Location |
Cell and gene therapeutic services are provided to biopharmaceutical firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ori Biotech
Frequently Asked Questions about Ori Biotech
When was Ori Biotech founded?
Ori Biotech was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Ori Biotech located?
Ori Biotech is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Ori Biotech?
Jason C Foster is the current CEO of Ori Biotech.
Is Ori Biotech a funded company?
Ori Biotech is a funded company, having raised a total of $281.12M across 6 funding rounds to date. The company's 1st funding round was a Series A of $30.3M, raised on Nov 09, 2016.
What does Ori Biotech do?
Ori Biotech was founded in 2015 and is based in London, United Kingdom. Software development services tailored to the biopharma sector are delivered by the company. Operations center on creating tools and solutions for biopharmaceutical processes. Leadership includes Co-Founders Chris Mason and Farlan Veraitch, alongside CEO Jason C Foster. Focus remains on supporting sector-specific needs through technical expertise.
Who are the top competitors of Ori Biotech?
Ori Biotech's top competitors include MaSTherCell, OBiO Technology and Genflow Biosciences.
Who are Ori Biotech's investors?
Ori Biotech has 8 investors. Key investors include Novalis LifeSciences, Puhua Capital, Chimera Investment, Amadeus Capital Partners, and Delin Ventures.
What is Ori Biotech's valuation?
The valuation of Ori Biotech is $62.6M as of Sep 2020.